Velká Británie - angličtina - MHRA (Medicines & Healthcare Products Regulatory Agency)

de pharmaceuticals - temazepam - oral tablet - 10mg

Velká Británie - angličtina - MHRA (Medicines & Healthcare Products Regulatory Agency)

ethigen ltd - temazepam - oral tablet - 10mg

Velká Británie - angličtina - MHRA (Medicines & Healthcare Products Regulatory Agency)

cavendish pharmaceuticals ltd - temazepam - oral tablet - 10mg

Velká Británie - angličtina - MHRA (Medicines & Healthcare Products Regulatory Agency)

national generics - temazepam - oral tablet - 10mg

Velká Británie - angličtina - MHRA (Medicines & Healthcare Products Regulatory Agency)

f.maltby & sons ltd - temazepam - oral tablet - 10mg

Velká Británie - angličtina - MHRA (Medicines & Healthcare Products Regulatory Agency)

b&s healthcare ltd - temazepam - oral tablet - 10mg

Velká Británie - angličtina - MHRA (Medicines & Healthcare Products Regulatory Agency)

norchem ltd - temazepam - oral tablet - 10mg

Velká Británie - angličtina - MHRA (Medicines & Healthcare Products Regulatory Agency)

colorama pharmaceuticals ltd - temazepam - oral tablet - 10mg

Velká Británie - angličtina - MHRA (Medicines & Healthcare Products Regulatory Agency)

almus pharmaceuticals ltd - temazepam - oral tablet - 10mg

Spojené státy - angličtina - NLM (National Library of Medicine)

physicians total care, inc. - cilostazol (unii: n7z035406b) (cilostazol - unii:n7z035406b) - cilostazol 100 mg - cilostazol tablets, usp are indicated for the reduction of symptoms of intermittent claudication, as indicated by an increased walking distance. cilostazol and several of its metabolites are inhibitors of phosphodiesterase iii. several drugs with this pharmacologic effect have caused decreased survival compared to placebo in patients with class iii-iv congestive heart failure. cilostazol tablets, usp are contraindicated in patients with congestive heart failure of any severity. cilostazol tablets, usp are contraindicated in patients with haemostatic disorders or active pathologic bleeding, such as bleeding peptic ulcer and intracranial bleeding. cilostazol tablets, usp inhibit platelet aggregation in a reversible manner. cilostazol tablets, usp are contraindicated in patients with known or suspected hypersensitivity to any of its components.